Purpose 1,1-Bis(3-indolyl)-1-(p-substituted phenyl)methanes (C-DIMs) substituted in the phenyl ring with a para-, t-butyl, triXuoromethyl (DIM-C-pPhCF 3 ) or phenyl (DIM-C-pPhC 6 H 5 ) group activate peroxisome proliferatoractivated receptor (PPAR ) in several cancer cell lines, and DIM-C-pPhCF 3 also activates the orphan receptor Nur77. In this study, we have examined the eVects of 5,5Ј-dihydroxy, 5,5Ј-dimethyl, 5,5Ј-dibromo, 5,5Ј-dinitro and 5,5Ј-dimethoxyindole ring-substituted analogs of DIM-CpPhC 6 H 5 on their activity as PPAR agonists. Methods Various substituted C-DIM analogs were used to investigate their growth-inhibitory activities and activation of PPAR -mediated transactivation in colon and pancreatic cancer cells. Their structure-dependent induction of putative PPAR -responsive genes/proteins including p21, KLF-4 and caveolin1 were also determined by Western and Northern blot analysis. Results Introduction of the 5,5Ј-dihydroxy and 5,5Ј-dimethyl substituents enhanced activation of PPAR in colon and pancreatic cancer cells. However, activation of p21 in Panc28 pancreatic cancer cells and induction of caveolin-1 and KLF4 in colon cancer cells by the C-DIM compounds were structure-and cell context-dependent. Conclusions The results demonstrate that DIM-CpPhC 6 H 5 and indole ring-substituted analogs are selective PPAR modulators.
Introduction
1,1-Bis(3Ј-indolyl)methane (DIM) is a metabolite of the phytochemical indole-3-carbinol and DIM has been used as scaVold to synthesize a series of 1,1-bis(3Ј-indolyl)-1-(psubstituted phenyl)methanes (C-DIMs) [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . These compounds are triarylmethane derivatives which diVer from DIM and ring-substituted DIMs which are diarylmethanes. Initial studies showed that some C-DIMs inhibited carcinogen-induced rat mammary tumor growth and growth of various cancer cell lines [1] [2] [3] [4] [5] 8] . The activation of several orphan nuclear receptors by a series of C-DIMs containing various p-substituents has also been determined and the results showed that some analogs activated PPAR in breast cancer cells [8] . Subsequent studies showed that one or more of the three most active compounds, namely the p-triXuoromethyl (DIM-C-pPhCF 3 ), p-t-butyl (DIM-CpPhtBu), and p-phenyl (DIM-C-pPhC 6 H 5 ) analogs also activated PPAR in colon, pancreatic, prostate, bladder, breast, endometrial and kidney cancer cell lines [1] [2] [3] [4] [5] [6] [8] [9] [10] [11] [12] . The PPAR -active C-DIMs exhibit highly tissue-speciWc receptor-dependent activation of responses and genes. For example, these compounds induced PPAR -dependent p21 gene expression in Panc28 pancreatic cancer cells and caveolin-1 in colon and bladder cancer cells [1] [2] [3] , whereas caveolin-1 is downregulated in prostate cancer cells by these compounds and the response is PPAR -independent [6] . Many other responses such as C-DIM-induced proapoptotic and growth-inhibitory eVects were also PPARindependent.
PPAR -active C-DIMs also induce other proapoptotic responses that are both receptor-and ER stress-independent. For example, in SW480 colon cancer cells, DIM-C-pPhCF 3 and DIM-C-pPhC 6 H 5 do not induce typical markers of ER stress and, in both SW480 and HCT116 colon cancer cells, C-DIM compounds induce expression of nonsteroidal anti-inXammatory drug-activated gene-1 (NAG-1) and activating transcription factor 3 (ATF3) which are proapoptotic genes and proteins [4, 15] . DIM also induces NAG-1 and ATF3 in HCT116 cells; however, the mechanism of this response has not been determined. Induction of NAG-1 in HCT116 cells by PPAR -active C-DIMs is dependent on PI3-K-dependent activation of early growth response-1 (Egr-1) gene which in turn activates NAG-1 through interactions with a proximal Egr-1 element in the NAG-1 promoter [4] . In contrast, induction of NAG-1 by DIM-C-pPhCF 3 in LNCaP cells is MAPK-dependent [6] and suggests that induction of some proapoptotic genes such as NAG-1 are dependent on activation of kinase pathways by C-DIMs. It is clear from studies on C-DIM compounds that DIM is an excellent scaVold from which new chemotherapeutic agents can be derived. In this study, we have synthesized a series of symmetrical 5Ј-indole ringsubstituted analogs of DIM-C-pPhC 6 H 5 and have investigated their cytotoxicity and PPAR -dependent activity in colon and pancreatic cancer cells.
Materials and methods
Cell lines and reagents SW480, HT-29 and HCT-15 human colon cancer cells, Panc-1 and Panc-28 human pancreatic cancer cells were obtained from American Type Culture Collection (Manassas, VA). SW480, HT-29, Panc-1 and Panc-28 cells were maintained in Dulbecco's modiWed/Ham's F-12 (SigmaAldrich, St Louis, MO) with phenol red supplemented with 0.22% sodium bicarbonate, 0.011% sodium pyruvate, 5% fetal bovine serum and 10 ml/l 100£ antibiotic antimycotic solution (Sigma). HCT-15 cells were maintained in RPMI 1640 (Sigma) supplemented with 0.22% sodium bicarbonate, 0.011% sodium pyruvate, 0.45% glucose, 0.24% N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid, 10% fetal bovine serum and 10 ml/l of 100£ antibiotic anti-mycotic solution (Sigma). Cells were maintained at 37°C in the presence of 5% CO 2 . Reporter lysis buVer and luciferase reagent for luciferase studies were supplied by Promega (Madison, WI). -Galactosidase ( -Gal) reagent was obtained from Tropix (Bedford, MA), and LipofectAMINE reagent was purchased from Invitrogen (Carlsbad, CA). The PPAR antagonist N-(4Ј-aminopyridyl)-2-chloro-5-nitrobenzamide (T007) was synthesized in our laboratory, and its identity and purity (>98%) was conWrmed by gas chromatography mass spectrometry. The C-DIMs compounds were all prepared by condensation of indole or ring-substituted indoles with substituted benzaldehydes essentially as described [8] .
Cell proliferation assay
This assay was performed in 12-well tissue culture plates using an initial concentration of 2 £ 10 4 cells per well, and Dulbecco's modiWed Eagle's medium (DMEM)/Ham's F-12 media containing 2.5% charcoal-stripped fetal bovine serum (FBS). Cells were counted on the initial day using a Z1 cell counter (Beckman Coulter, Fullerton, CA) and then treated either with vehicle [dimethyl sulfoxide (DMSO)] or the indicated indole ring-substituted C-DIM compounds. Every 48 h, fresh medium was added along with the indicated compounds. Cell counts were taken after 24, 48, 72 and 96 h. The results are expressed as mean § standard errors for at least three samples for each treatment group.
Transfection assays
The Gal4 reporter containing Wve Gal4 response elements (pGal4) was kindly provided by Dr. Marty Mayo (University of North Carolina, Chapel Hill, NC). Gal4DBD-PPAR construct was a gift of Dr. Jennifer L. OberWeld (GlaxoSmithKline Research and Development). Cells were seeded in 12-well plates, and 0.4 g of GAL4-Luc, 0.04 g of -GAL, 0.04 g of GAL4DBD-PPAR were transfected using LipofectAMINE reagent (Invitrogen) following the manufacturer's protocol. Cells were treated either with vehicle or with respective compounds suspended in complete medium after 6 h of transfection. Cell lysates were extracted after treatment for 20-22 h by adding 100 l of 1£ reporter lysis buVer per well, and 30 l of this extract was used to quantitate the luciferase activity using Lumicount (Perkin-Elmer Life and Analytical Sciences). Each experiment was conducted in triplicate and the results were normalized to the -GAL activity. ) pancreatic cancer cells were seeded in 6-well tissue culture plates in DMEM/Ham's F-12 medium containing 2.5% charcoal-stripped FBS. Protein was extracted from the cells treated either with vehicle or with the indicated compounds for 24 h for p21 protein, or 72 h for caveolin-1 protein. Samples were extracted in high salt buVer [50 mmol/l N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid, 500 mmol/l NaCl, 1.5 mmol/l MgCl 2 , 1 mmol/l ethyleneglycol-bis(aminoethylether)-tetraacetic acid, 10% glycerol and 1% Triton X-100 (pH 7.5) and 5 l/ml protease inhibitor cocktail (Sigma-Aldrich)]. Extracts were incubated at 100°C for 2 min, separated on either 10 or 12% sodium dodecylsulfate-polyacrylamide gel electrophoresis gels and then transferred to polyvinylidene diXuoride membrane (Bio-Rad, Hercules, CA). The polyvinylidene diXuoride membrane was blocked in 5% TBST-Blotto (10 mM Tris-HCl, 150 mM NaCl, pH 8.0, 0.05% Triton X-100 and 5% non-fat dry milk) for 30 min and then incubated in fresh 5% TBST-Blotto with 1:1,000 for caveolin-1 (Santa Cruz Biotechnology, Santa Cruz, CA), 1:1,000 for p21 (BD Pharmingen, Franklin Lakes, NJ) and 1:2,000 for -tubulin (Santa Cruz Biotechnology, Santa Cruz, CA) primary antibody overnight with gentle shaking at 4°C. After washing with Tris-buVered saline containing Tween-20 (TBST) for 10 min, the membrane was incubated with respective secondary antibody (1:5,000) (Santa Cruz Biotechnology) in 5% TBST-Blotto for 3 h. The membrane is then washed with TBST for 10 min, incubated with chemiluminescence reagent from Perkin-Elmer for 1 min and then exposed to Kodak X-OMAT AR autoradiography Wlm (Eastman Kodak, Rochester, NY).
Semi-quantitative reverse transcription polymerase chain reaction SW480 and HT29 colon cancer cells were treated either with vehicle (DMSO) or with indicated indole ring-substituted C-DIMs compounds and, after 24 h total, RNA was extracted using RNeasy kit (Qiagen, Valencia, CA). RNA concentration was measured by UV 260:280 nm absorption ratio, and 2 g RNA was used to synthesize cDNA using Reverse Transcription System (Promega). Polymerase chain reaction (PCR) conditions were as follows: initial denaturation at 94°C (1 min) followed by 28 cycles of denaturation for 30 s at 94°C, annealing for 60 s at 55°C, and extension at 72°C for 60 s and a Wnal extension step at 72°C for 5 min. mRNA levels were normalized to GAPDH as an internal housekeeping gene. Primers were obtained from IDT (Coralville, IA) and used for ampliWcation as follows: KLF4 (sense 5Ј-CTA TGG CAG GGA GTC CGC TCC-3Ј; anti-sense 5Ј-ATG ACC GAC GGG CTG CCG TAC-3Ј) and GAPDH (sense 5Ј-ACG GAT TTG GTC GTA TTG GGC G-3Ј; anti-sense 5Ј-CTC CTG GAA GAT GGT GAT GG-3Ј). PCR products were electrophoresed on 1% agarose gels containing ethidium bromide and visualized under UV transillumination.
Quantitative real-time PCR cDNA was prepared from the RKO cells using Reverse Transcription System (Promega). Each PCR was carried out in triplicate in a 30-l volume using SYBR Green Mastermix (Applied Biosystems, Foster city, CA) for 15 min at 95°C for initial denaturing, followed by 40 cycles of 95°C for 30 s and 60°C for 1 min in the Applied Biosystems 7900HT Fast Real-Time PCR System. The ABI Dissociation Curves software was used following a brief thermal protocol (95°C 15 s and 60°C 15 s, followed by a slow ramp to 95°C) to control for multiple species in each PCR ampliWcation. Values for each gene were normalized to expression levels of TATA-binding protein (TBP). The primers used for real-time-PCR were obtained from Qiagen Inc. (Valencia, CA).
Results

Growth inhibition by indole ring-substituted C-DIMs
It has previously been shown that DIM-C-pPhC 6 H 5 ( Fig. 1 ) inhibited growth of several diVerent cancer cell lines and also activated PPAR [1, 3] . In this study, we have examined the eVects of various symmetrical 5,5Ј-indole ringsubstituted analogs of DIM-C-pPhC 6 H 5 and determined the eVects of substituent structure on the cytotoxicity and PPAR agonist activity of these compounds in Panc28 pancreatic cancer cells and SW480 colon cancer cell lines. Figure 2 summarizes the cytotoxicity of DIM-C-pPhC 6 H 5 and the 5,5Ј-substituted nitro (NO 2 ), bromo (Br), hydroxyl (OH), methyl (Me) and methoxy (OMe) analogs in Panc28 cells. All compounds caused a concentration-dependent decrease in cell counts after treatment for 24, 48, 72 or 96 h, and similar results were observed in colon cancer cells (data not shown). Table 1 summarizes the growth-inhibitory IC 50 values at all time points. There was less than a 2.5-fold diVerence in IC 50 values among the six C-DIM compounds in both cell lines, suggesting that introduction of the 5,5Ј-substituents on the indole ring do not substantially enhance or decrease the cytotoxicity of DIM-C-pPhC 6 H 5 . The eVects of the indole ring substituents on the activation of PPAR by DIM-C-pPhC 6 H 5 and related compounds were investigated in SW480 colon cancer cells transfected with GAL4-PPAR /GAL4-luc constructs. Treatment of SW480 colon cancer cells with 5.0 M DIM-C-pPhC 6 H 5 (X=H) showed that the 5,5Ј-dihydroxy and 5,5Ј-dimethyl (X=OH and Me, respectively) analogs signiWcantly induced luciferase activity and, at a lower concentration of 2.5 M, transactivation was induced only with the indole ringsubstituted analogs and not DIM-C-pPhC 6 H 5 (Fig. 3a) . The results indicate that the 5,5Ј-dihydroxy and 5,5Ј-dimethyl compounds were more active than the unsubstituted compound DIM-C-pPhC 6 H 5 , and the 5,5Ј-dinitro, 5,5Ј-dibromo and 5,5Ј-dimethoxy analogs were inactive at this concentration and higher doses (>5.0 M) were cytotoxic. The eVects of the 5,5Ј-dimethyl and 5,5Ј-dihydroxy substituents on activation of PPAR -dependent activity by DIM-C-pPhCF 3 and DIM-C-pPhtBu were compared to the results obtained for the corresponding X-DIM-C-pPhC 6 H 5 compounds in SW480 cells transfected with PPAR -GAL4/pGAL4 (Fig. 3b) . The results show that introduction of 5,5Ј-dimethyl or -dihydroxy groups enhanced PPAR -dependent Fig. 2 Cell proliferation assays. Panc28 cells were treated with X-DIM-C-pPhC 6 activity for all three PPAR -active C-DIMs. In SW480 cells transfected with PPAR -GAL4/pGAL4, induction of luciferase activity by DIM-C-pPhC 6 H 5 and the 5,5Ј-dihydroxy and -dimethyl analogs was inhibited after cotreatment with 10 M T007, a PPAR antagonist (Fig. 3c) . Figure 4 summarizes the structure-dependent activation of luciferase activity in Panc1 cells treated with DIM-C-pPhC 6 H 5 and the 5,5Ј-ring-substituted analogs of this C-DIM. In this cell line, 2.5 and 5 M concentration of the 5,5Ј-dihydroxy, 5,5Ј-dimethyl and 5,5Ј-dimethoxy analogs were active, whereas 5 M DIM-C-pPhC 6 H 5 did not induce luciferase activity. Higher concentration of this compound only weakly induced luciferase activity (data not shown). Thus, the 5,5Ј-dihydroxy and 5,5Ј-dimethyl substituted compounds were PPAR agonists in both cell lines, whereas the 5,5Ј-dimethoxy analog activated PPAR in Panc1 but not SW480 cells (Fig. 3a) .
A comparison of the activation of PPAR -active DIM-C-pPhCF 3 , DIM-C-pPhtBu and DIM-C-pPhC 6 H 5 and their 5,5Ј-dimethyl and 5,5Ј-dihydroxy derivatives in Panc1 cells is shown in Fig. 4b . Treatment with 2.5 M concentration of the C-DIMs induced luciferase activity in Panc1 cells with 7 out of 9 compounds, only DIM-C-pPhC 6 H 5 and the 5,5Ј-dihydroxy derivative of DIM-C-pPhtBu were inactive. These results were similar to those observed in SW480 cells (Fig. 3b) , except that the 5,5Ј-dihydroxy derivative of DIM-C-pPhtBu induced transactivation in colon but not in pancreatic cancer cells.
The PPAR agonist activity of DIM-C-pPhC 6 H 5 and the 5,5Ј-dihydroxy and 5,5Ј-dimethyl derivatives in Panc1 cells transfected PPAR -GAL4/pGAL4 was inhibited in cells cotreated with the PPAR antagonist T007 (10 M) (Fig. 4c) ; however, the inhibitory eVects of T007 were less pronounced in Panc1 cells compared to that observed in SW480 cells (Fig. 3) .
Activation of KLF4 and caveolin-1 by indole ring-substituted C-DIMs in colon cancer cells Previous studies show that KLF4 is activated by the PPAR agonist methyl-2-cyano-3,11-dioxo-18 -olean-1,12-dien-30-oate (CDODA-Me) in colon cancer cells and these induction responses are inhibited by the PPAR antagonist T007 [16] . Results in Fig. 5a show that DIM-C-pPhC 6 H 5 and the 5,5Ј-dihydroxy and 5,5Ј-dimethyl analogs also induce KLF4 mRNA levels in SW480 colon cancer cells after treatment for 24 h. However, the induction response is only observed after treatment of SW480 or HT-29 cells with a relatively high concentration (12.5 M) of these compounds. With the exception of 5,5Ј-dimethyl analog, the dose-response curves for induction of KLF4 were steep and only observed at the high (12.5 M) concentration and this contrasted to the concentration-dependent activation of PPAR -GAL4/GAL4 by these compounds (Figs. 3, 4) . Semi-quantitative RT-PCR analysis of KLF4 mRNA induction by the C-DIM compounds alone or in combination Fig. 3 X-DIM-C-pPhC 6 H 5 activates PPAR in SW480 cells. a Activation by X-DIM-C-pPhC 6 H 5 . SW480 cells were transfected with PPAR -Gal4/pGal4 and treated with DMSO or diVerent concentrations of X-DIM-C-pPhC 6 H 5 (X=H, X=NO 2 , X=Br, X=OH, X=Me and X=OMe), and luciferase activity was determined as described in "Materials and methods". b Activation by PPAR -active DIM-CpPhCF 3 , DIM-C-pPhtBu and DIM-C-pPhC 6 H 5 and their 5,5Ј-dimethyl and 5,5Ј-dihydroxy derivatives. SW480 cells were treated as in (a), and luciferase activity was determined as described in "Materials and methods". Mean of three replicate determinations for each treatment group (columns); bars indicate SE. *P < 0.05, signiWcant induction. c EVects of PPAR antagonist T007 on induced transactivation in SW480 cells transfected with PPAR -GAL4/pGAL4. Induction of luciferase activity by DIM-C-pPhC 6 H 5 and the 5,5Ј-dihydroxy and 5,5Ј-dimethyl analogs was inhibited in cells cotreated with 10 M T007, a PPAR antagonist. Mean of three replicate determinations for each treatment group (columns); bars indicate SE; *P < 0.05, signiWcant induction; **P < 0.05, signiWcant inhibition with the PPAR antagonist T007 is illustrated in Fig. 5b . The results conWrm that the C-DIMs induce KLF4 expression in colon cancer cells; however, the lack of inhibition by T007 suggests that the induction response was PPARindependent. PPAR -independent induction of KLF4 by the C-DIMs was similar to results of a previous report showing that induction of KLF4 mRNA in colon cancer cells by the PPAR agonist 15-deoxy-12,14 -prostaglandin J2 (PGJ2) was receptor-independent [17] , whereas induction of KLF4 mRNA in colon cancer cells by CDODA-Me was receptor-dependent [16] .
Previous studies showed that PPAR -active C-DIMs induced caveolin-1 protein expression in colon cancer cells and the induction response was observed only after treatment for 48-72 h but was inhibited by PPAR antagonists [3] . Figure 6 illustrates the eVects of 5 M DIM-CpPhC 6 H 5 and related indole ring-substituted compounds on expression of caveolin-1 after treatment of HT-19, HCT-15 and SW480 cells for 72 h. Induction of caveolin-1 was not observed in HCT-15 cells (Fig. 6a) ; however, all three CDIMs alone induced caveolin-1 in HT-29 cells (Fig. 6b) , whereas only DIM-C-pPhC 6 H 5 and the 5,5Ј-dihydroxy but not the 5,5Ј-dimethyl analogs induced caveolin-1 in SW480 cells (Fig. 6c) . The eVects of T007 on induction of caveolin-1 by C-DIMs in HT-29 cells were diYcult to decipher due to induction of caveolin-1 by T007 alone. However, T007 inhibited caveolin-1 induction by DIM-C-pPhC 6 H 5 and the dihydroxy analog in HT-29 and SW480 cells. These results show that induction of caveolin-1 by C-DIMs was dependent on cell context since induction was observed in HT-29 and SW480 but not HCT-15 cells. In addition, induction of caveolin-1 was also structure-dependent since all three analogs were inducers in HT-29 cells (Fig. 6b) , whereas the 5,5Ј-dimethyl-substituted C-DIM was inactive in SW480 cells (Fig. 6c) , suggesting that these indole ring-substituted analogs of DIM-C-pPhC 6 H 5 are selective PPAR modulators.
Activation of p21 by indole ring-substituted C-DIMs in pancreatic cancer cells Figure 6d shows that both DIM-C-pPhC 6 H 5 (#9) and DIM-C-pPhCF 3 (#1) induce p21 protein expression in Panc28 cells and the induction response by the latter compound was previously reported [1] . The 5,5Ј-dimethyl analog of DIM-C-pPhC 6 H 5 also induced p21 protein but the corresponding 5,5Ј-dihydroxy indole ring-substituted compound was inactive at a concentration of 12.5 M. However, the eVects of DIM-C-pPhC 6 H 5 and the 5,5Ј-dihydroxy and 5,5Ј-dimethyl analogs on p21 expression were unaVected after cotreatment with the PPAR antagonistGW9662. These results suggest that in Panc28 cells, DIM-C-pPhC 6 H 5 and related compounds enhance PPAR -independent expression of p21, whereas previous studies reported induction of p21 by DIM-C-pPhCF 3 in Panc28 cells was PPARdependent [1] . These results suggest that even among "PPAR-active" unsubstituted C-DIMs, their eVects on Panc1 cells were transfected with PPAR -Gal4/pGal4 and treated with DMSO or diVerent concentrations of X-DIM-C-pPhC 6 H 5 (X=H, X=NO 2 , X=Br, X=OH, X=Me and X=OMe), and luciferase activity was determined as described in "Materials and methods". b Activation of PPAR -active DIM-CpPhCF 3 , DIM-C-pPhtBu and DIM-C-pPhC 6 H 5 and their 5,5Ј-dimethyl and 5.5Ј-dihydroxy derivatives. Panc1 cells were treated as described in (a), and luciferase activity was determined as described in "Materials and methods". Mean of three replicate determinations for each treatment group (columns); bars indicate SE; *P < 0.05, signiWcant induction. c EVects of PPAR antagonist T007 on induced transactivation in Panc1 cells. Cells were transfected with PPAR -GAL4/pGAL4, induction of luciferase activity by DIM-C-pPhC 6 H 5 and the 5,5Ј-dihydroxy and 5,5Ј-dimethyl analogs was inhibited after cotreatment with 10 M T007, a PPAR antagonist. Mean of three replicate determinations for each treatment group (columns); bars indictae SE; *P < 0.05, signiWcant induction; **P < 0.05, signiWcant inhibition induction of p21 indicate that these compounds are selective receptor modulators.
Discussion
PPAR is a member of the nuclear receptor family of ligand-activated receptors, and the transcriptionally active complex is a heterodimer containing PPAR and the retinoid X receptor (RXR). The thiazolidinedione class of PPAR agonists has been used extensively for treatment of type II diabetes, and there is evidence that these compounds may have applications for treating other diseases including atherogenesis and cancer [18, 19] . PPAR is overexpressed in multiple tumor types, and several studies show the eVectiveness of diVerent structural classes of PPAR agonists for inhibiting cancer cell growth and inducing apoptosis. Typically, these compounds induce diVerentiation in cancer cells and inhibit G 0 /G 1 to S phase progression which is associated with decreased expression of cyclin D1 and induction of the cyclin-dependent kinase inhibitors p21 and/or p27. Mechanistic studies using PPAR antagonists (T007 and GW9662) and PPAR knockdown by RNA interference demonstrate that many of the growth inhibitory and proapoptotic responses induced by PPAR agonists are receptor-independent [4-6, 14, 15] .
Nuclear receptor agonists typically bind structurally diverse compounds and this has also been observed for PPAR . For example, PPAR binds and is activated by endogenous biochemicals such as fatty acids and 15-deoxy-12,14 -prostaglandin J2 (PGJ2), Xavonoids and various synthetic compounds including substituted indoles and chromane carboxylic acids, phosphono-phosphates, PPAR -active C-DIMs, CDODA-Me and triterpenoids such as 2-cyano-3,12-dioxo-18 -oleana-1,9-dien-28-oic acid (CDDO) and related derivatives [20] [21] [22] [23] [24] [25] [26] . Not surprisingly, there is evidence that among this structurally diverse group of compounds, PPAR agonists exhibit tissue-/cell-and response-speciWc diVerences suggesting that these compounds are selective PPAR modulators. For example, induction of NAG-1 by PGJ2 in colon cancer cells was receptor-dependent, whereas induction of this gene by other PPAR agonists such as thiazolidinediones and C-DIMs was receptor-independent [4, 27, 28] . Moreover, research in our laboratory on -and -CDODA-Me, which are triterpenoids that exhibit diVerent stereochemistries at C18, and a structurally related 2-cyanobetulinic acid derivative (CN-BA) also exhibited response-and cell context-dependent . Cells were treated with diVerent concentrations of DIM-C-pPhC 6 H 5 (#9) and the 5,5Ј-dihydroxy and 5,5Ј-dimethyl analogs or T007 alone or in combination for 24 h, and KLF4 mRNA levels were determined by real-time polymerase chain reaction (a) or semiquantitative RT-PCR (b) as described in the "Materials and methods". Each experiment was replicated (>3£). T007 did not inhibit KLF4 mRNA induction by DIM-C-pPhC 6 H 5 and the 5,5Ј-dihydroxy and 5,5Ј-dimethyl analogs. TBP and GAPDH mRNA levels were used to normalize KLF4 mRNA levels in the two experiments and the fold-change in the induction of KLF4 mRNA by C-DIMs is compared to the solvent (DMSO) control (set at 1.0) diVerences [16, 29] . Previous studies with PPAR -active CDIMs showed that DIM-C-pPhCF 3 induced p21 in Panc28 cells and all three PPAR -active C-DIMs induced caveolin-1 in colon cancer cells and these responses were inhibited after cotreatment with PPAR antagonists T007 or GW9662 [1, 3] . Moreover, we have also shown that PPAR -active triterpenoids induce KLF4 mRNA in a receptor-dependent manner in some colon cancer cell lines [16, 29] . Therefore, in this study, we Wrst examined the cytotoxicity of DIM-C-pPhC 6 H 5 and symmetrical 5,5Ј-indole ring substituents and their activation of PPAR (Fig. 1) . The second objective was to determine whether these compounds were selective PPAR modulators with respect to activation of caveolin-1, KLF-4 and p21.
Results illustrated in Fig. 2 and Table 1 show that the growth-inhibitory IC 50 values for DIM-C-pPhC 6 H 5 and several indole ring-substituted analogs in SW480 colon and Panc28 pancreatic cancer cells were similar and varied between 1 and 10 M at all time points in both cell lines. Thus, introduction of a 5-methyl, 5-nitro, 5-bromo, 5-hydroxy or 5-methoxy into both indole rings did not substantially enhance or inhibit their cytotoxic eVects compared to the unsubstituted DIM-C-pPhC 6 H 5 .
The comparative activation of PPAR by DIM-CpPhC 6 H 5 and X-DIM-C-pPhC 6 H 5 analogs was determined in Panc1 and SW480 cells transfected with PPAR -GAL4/ pGAL4 constructs (Figs. 3, 4 ). Panc1 cells were used instead of Panc28 cells because of the higher transfection eYciency in the former cell line. In previous studies in colon cancer cells, we observed that activity of the unsubstituted C-DIMs in this assay was comparable to that observed for similar concentrations of rosiglitazone, although there was some variability between DIM-CpPhCF 3 , DIM-C-pPhtBu and DIM-C-pPhC 6 H 5 [3] . In SW480 cells, the 5,5Ј-dihydroxy and 5,5Ј-dimethyl analogs induced PPAR -dependent transactivation and were clearly more potent than the DIM-C-pPhC 6 H 5 (Fig. 3) . Moreover, 5,5Ј-dihydroxy and 5,5Ј-dimethyl analogs of DIM-CpPhC 6 H 5 and DIM-C-pPhtBu also induced transactivation in SW480 cells transfected with PPAR -GAL4/pGAL4 demonstrating that introduction of these substituents enhanced the PPAR agonist activities of other PPARactive C-DIMs in SW480 (Fig. 2 ) and Panc1 cells (Fig. 4) . With one exception, similar structure-activity relationships for activating PPAR were observed in SW480 and Panc1 cells (Fig. 4) where the 5,5Ј-dihydroxy and 5,5Ј-dimethyl analogs were active and the 5,5Ј-dinitro and 5,5Ј-dibromo analogs were inactive. However, it was also observed that the 5,5Ј-dimethoxy derivative also induced transactivation in Panc1 (but not SW480) cells at the 2.5 and 5.0 M concentrations used in this study. Higher doses were not used due to cytotoxicity but it is possible that the cell contextdependent diVerences observed for the 5,5Ј-dimethoxy derivative are due to potency diVerences for this compound as a PPAR agonist in the two cell lines. The inhibitory eVects of T007, a PPAR antagonist conWrms that DIM-CpPhC 6 H 5 and the 5,5Ј-dihydroxy and 5,5Ј-dimethyl analogs are PPAR agonists (Figs. 3, 4) and these compounds and possibly the 5,5Ј-dimethoxy derivative further extend the number of C-DIMs that activate PPAR . It is apparent that the PPAR agonist activities of indole ring-substituted DIM-C-pPhC 6 H 5 are structure-dependent; however, the ,5Ј-dimethyl analogs alone or in combination with 10 M T007 and caveolin-1 expression was determined by western blot analysis as described in the "Materials and methods". d Induction of p21 in Panc28 cells. Cells were treated with C-DIMs alone or in combination with the PPAR agonist GW9662 and, after 24 h, whole cell lysates were analyzed by western blot analysis as described in the "Materials and methods" 123 cytotoxicities of these compounds are comparable, suggesting that this important aspect of their anticarcinogenic activity is PPAR -independent. This observation is consistent with a recent study showing that the antiproliferative activities of PPAR -active C-DIMs were not aVected after cotreatment with PPAR antagonists [1] .
Previous reports show that some PPAR agonists induce KLF4 in colon cancer cells; however, this response is structure and cell context-dependent. -and -CDODA-Me induced KLF4 expression in HT-29 and SW480 but not HCT-15 cells, whereas the 2-cyano derivative of betulinic acid induced KLF4 in HT-29 but not SW480 cells [16, 29] . All three compounds are PPAR agonists but induction of KLF4 by -and -CDODA-Me was receptor-dependent and induction by the cyano betulinic acid derivative was PPAR -independent. Similar results were observed in this study (Fig. 5) where induction of KLF4 by DIM-CpPhC 6 H 5 and the 5,5Ј-dihydroxy and 5,5Ј-dimethyl analogs in SW480 and HT-29 cells was not inhibited after cotreatment with T007.
Receptor-dependent induction of caveolin-1 by CDODA-Me, PPAR -active C-DIMs and CN-BA has been reported in colon cancer cells; however, the induction responses were cell context-dependent [3, 16, 29] . For example, CN-BA induced caveolin-1 in HT-29 and HCT-15 cells but not SW480 cells, whereas -CDODA-Me induces caveolin-1 in all three cell lines [16, 29] . In this study, 5 M DIM-C-pPhC 6 H 5 and the 5,5Ј-dihydroxy and 5,5Ј-dimethyl analogs induced caveolin-1 protein in HT-29 and SW480 cells (Fig. 6 ), and cotreatment with T007 inhibited the response in the latter cell line. In contrast, we did not observe induction of caveolin-1 in HCT-15 cells. The inhibitory response was not well-deWned in HT-29 cells due to induction of caveolin-1 by T007 alone. Nevertheless, the pattern of caveolin-1 induction in the two cell lines by the indole ring-substituted compounds was similar to that previously described for PPAR -active C-DIMs in these same cell lines [3] . However, in this study, the failure to observe induction in HCT-15 cells was inconsistent with previous studies with C-DIMs in this cell line, and the diVerences observed are currently being reinvestigated.
In Panc28 cells, DIM-C-pPhCF 3 induced p21 expression that was PPAR -dependent [1] , and Fig. 6d conWrms that both DIM-C-pPhC 6 H 5 (#9) and DIM-C-pPhCF 3 (#1) induce p21 protein in this cell line. The 5,5Ј-dimethyl analog of DIM-C-pPhC 6 H 5 also induced p21 protein but the corresponding 5,5Ј-dihydroxy analog was inactive at a concentration of 12.5 M. Moreover, the eVects of DIM-CpPhC 6 H 5 and the 5,5Ј-dihydroxy and 5,5Ј-dimethyl analogs on p21 expression were unaVected after cotreatment with the PPAR antagonist T007. These results suggest that in Panc28 cells, DIM-C-pPhC 6 H 5 and related compounds enhance PPAR -independent expression of p21, whereas previous studies reported that induction of p21 by DIM-CpPhCF 3 in Panc28 cells was PPAR -dependent [1] .
These results observed in colon and pancreatic cancer cells further demonstrate that indole ring-substituted analogs of DIM-C-pPhC 6 H 5 activate PPAR and some PPAR -mediated responses in colon cancer cells. However, the role of the receptor in mediating the responses is cell context-and structure-dependent. The results are consistent with previous studies showing that even among the unsubstituted PPAR -active DIM-C-pPhCF 3 , DIM-C-pPhtBu and DIM-C-pPhC 6 H 5 analogs, there were signiWcant diVerences in their eVects on PPAR -coactivator interactions in a mammalian two-hybrid assay [3] . It was also apparent that the PPAR -active and inactive C-DIM analogs exhibit comparable cytotoxicities suggesting that the antiproliferative activity of C-DIMs is primarily PPAR -independent. Currently, we are investigating structural modiWcation of C-DIMs at various positions in the indole and phenyl rings in order to maximize their PPAR agonist activities and cytotoxic eVects in cancer cell lines. In addition, since DIM-C-pPhCF 3 also activates the orphan receptor Nur77 [15] , we will also investigate the eVects of indole ring substituents on activation of this orphan nuclear receptor in pancreatic cancer cells.
